Related Experiment Video
Updated: Mar 13, 2026

Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging
Published on: June 14, 2021
Abstract:
Fosfomycin trometamol is a broad spectrum antibiotic recently marketed in the UK for the treatment of acute uncomplicated lower urinary tract infections (UTIs) in adults1,2 and in adult and adolescent females.3 It is also indicated for prophylaxis in diagnostic and surgical transurethral procedures.1-3 Fosfomycin was discovered in 1969 and the reference drug was first marketed as Monuril in France in 1986.3,4 Although Monuril had UK marketing authorisation, it was never distributed in the UK. However, national guidance included the option of using unlicensed imported fosfomycin.3,5,6 Branded and generic versions of fosfomycin are now available in the UK,1-3,7 and here we review the evidence for their use in the treatment of UTIs.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Urinary Tract Calculi III: Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Calculi V: Nursing Management

